The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer ...

Allogeneic hematopoietic cell transplantation (allo-HCT) is feasible in older patients with myelodysplastic syndrome (MDS), ...

Reblozyl sales surged 35% in Q1 for BMY, but a failed phase III study clouds expansion plans amid stiff anemia drug ...

Patients with myelodysplastic syndromes (MDS) who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT) are older and face worse outcomes compared with non-MDS patients, ...

Myelodysplastic syndromes are diseases of older patients. The median age in the United States is 76 years old, meaning that most of your patients are going to be in their eighth decade of life, ...

Myelodysplastic syndromes, also called myelodysplasia or MDS, is the name for a group of conditions that cause the number of normal blood cells to drop. In these syndromes, the bone marrow does ...

Some cancer treatments raise the risk of myelodysplastic syndromes. June 12, 2012— -- Jenna Langer was a high school senior when she was diagnosed with osteosarcoma, the most common form of ...

If you have MDS, a type of blood cancer called myelodysplastic syndrome, you’re part of a rare group of people with the diagnosis. But research is ongoing. Many clinical trials are seeking new ...

"Good Morning America" anchor Robert Roberts shared news today that she's facing a serious new health challenge: MDS or myelodysplastic syndrome. Dr. Richard Besser explains what MDS is and the ...

A. Myelodysplastic syndrome, or MDS, is a cancer of the bone marrow involving the stem cells that make up our blood — red blood cells, white blood cells and platelets. It is typically a slow ...